Xu Rena, Horick Nora, McGovern Francis J, Dahl Douglas M, Feldman Adam S, Blute Michael L, Olumi Aria F, Michaelson M Dror
Harvard Medical School, Boston, MA.
Massachusetts General Hospital Cancer Center, Boston, MA.
Urol Oncol. 2014 Apr;32(3):355-61. doi: 10.1016/j.urolonc.2013.09.001. Epub 2014 Jan 4.
Many patients with renal cell carcinoma (RCC) are found to have lung nodules at the time of diagnosis. The significance of these nodules is unclear. This study sought to determine whether the presence of indeterminate lung nodules affects survival for patients with early-stage RCC.
A retrospective review was performed of patients with stages I to III RCC at an academic hospital who underwent nephrectomy between 2001 and 2006 and had baseline imaging available for review. Presence of lung nodule(s) was determined, along with patient and disease characteristics. The time from diagnosis to last known follow-up, metastasis, and death were determined. The study follow-up period extended to July 2012. Univariate and multivariate Cox proportional hazards models assessed disease-free and overall survival.
Of 548 patients, 240 met the inclusion criteria. Lung nodules were absent in 148 and present in 92 cases. Disease-free survival was associated with the presence of nodules (hazard ratio [HR] = 1.90; 95% CI: 1.04-3.46; P = 0.0362), tumor stage (stage II-HR = 5.61; 95% CI: 2.69-11.72; P<0.001 and stage III-HR = 2.49; 95% CI: 1.21-5.10; P = 0.0129) and tumor grade (HR = 2.43 for grades 3 or 4; 95% CI: 1.31-4.53; P = 0.005). The number and size of nodules were not associated with survival. Overall survival was associated with Charlson comorbidity score (HR = 1.30; 95% CI: 1.15-1.47; P<0.0001) and primary tumor size (HR = 1.29; 95% CI: 1.14-1.46; P<0.0001) but not the presence of lung nodules (HR = 1.73; 95% CI: 0.83-3.60; P = 0.1454).
The presence of indeterminate lung nodules had a negative effect on disease-free survival. Stage and grade were also significant. These findings underscore the importance of baseline imaging and vigilant surveillance of patients in whom nodules are identified.
许多肾细胞癌(RCC)患者在诊断时被发现有肺结节。这些结节的意义尚不清楚。本研究旨在确定不确定肺结节的存在是否会影响早期RCC患者的生存率。
对一家学术医院2001年至2006年间接受肾切除术且有基线影像学资料可供复查的I至III期RCC患者进行回顾性研究。确定肺结节的存在情况以及患者和疾病特征。确定从诊断到最后一次已知随访、转移和死亡的时间。研究随访期延长至2012年7月。单因素和多因素Cox比例风险模型评估无病生存期和总生存期。
548例患者中,240例符合纳入标准。148例无肺结节,92例有肺结节。无病生存期与结节的存在相关(风险比[HR]=1.90;95%CI:1.04-3.46;P=0.0362)、肿瘤分期(II期-HR=5.61;95%CI:2.69-11.72;P<0.001,III期-HR=2.49;95%CI:1.21-5.10;P=0.0129)和肿瘤分级(3级或4级HR=2.43;95%CI:1.31-4.53;P=0.005)。结节的数量和大小与生存率无关。总生存期与Charlson合并症评分(HR=1.30;95%CI:1.15-1.47;P<0.0001)和原发肿瘤大小(HR=1.29;95%CI:1.14-1.46;P<0.0001)相关,但与肺结节的存在无关(HR=1.73;95%CI:0.83-3.60;P=0.1454)。
不确定肺结节的存在对无病生存期有负面影响。分期和分级也具有重要意义。这些发现强调了基线影像学检查以及对发现结节患者进行密切监测的重要性。